Medpace Holdings Inc (MEDP)
Profitability ratios
Return on sales
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross profit margin | 22.49% | 20.98% | 20.01% | 19.28% | 19.73% | 21.11% | 22.41% | 22.73% | 21.93% | 20.75% | 19.63% | 19.28% | 18.98% | 19.62% | 20.05% | 20.16% | 19.34% | 20.41% | 18.77% | 19.07% |
| Operating profit margin | 21.19% | 19.76% | 18.81% | 18.09% | 17.73% | 17.94% | 18.57% | 18.70% | 18.72% | 18.54% | 18.08% | 17.70% | 17.34% | 18.17% | 18.61% | 18.75% | 18.03% | 16.53% | 14.94% | 15.36% |
| Pretax margin | 22.57% | 20.92% | 19.58% | 18.48% | 17.67% | 17.54% | 18.48% | 18.88% | 19.00% | 19.12% | 18.46% | 17.98% | 17.63% | 18.34% | 18.75% | 18.90% | 18.19% | 16.74% | 15.03% | 15.34% |
| Net profit margin | 19.18% | 17.67% | 16.75% | 15.94% | 14.89% | 15.04% | 15.64% | 15.98% | 16.48% | 16.35% | 16.24% | 16.43% | 15.88% | 16.70% | 17.06% | 16.72% | 15.69% | 13.87% | 12.11% | 12.37% |
Based on the provided data, the profitability ratios of Medpace Holdings Inc have shown fluctuations over the analyzed period.
1. Gross Profit Margin: The gross profit margin, which indicates the percentage of revenue that exceeds the cost of goods sold, ranged from 18.77% to 22.73% during the period. There was a general upward trend in the gross profit margin, with a significant improvement from 18.77% in June 2020 to 22.49% in December 2024.
2. Operating Profit Margin: The operating profit margin, highlighting the proportion of revenue remaining after deducting operating expenses, fluctuated between 14.94% and 21.19%. The margin displayed an overall increasing trend, with a notable rise from 14.94% in June 2020 to 21.19% in December 2024.
3. Pretax Margin: The pretax margin, representing the earnings before taxes as a percentage of revenue, varied from 15.03% to 22.57% over the period. There was a general upward trajectory in the pretax margin, with a significant improvement from 15.03% in June 2020 to 22.57% in December 2024.
4. Net Profit Margin: The net profit margin, indicating the portion of revenue that translates into net income, fluctuated between 12.11% and 19.18%. The margin showed some volatility but demonstrated an overall increasing trend, with a notable increase from 12.11% in June 2020 to 19.18% in December 2024.
Overall, Medpace Holdings Inc's profitability ratios have shown improvement over the analyzed period, with increasing margins for gross, operating, pretax, and net profits. These trends indicate that the company has become more efficient in generating profits in relation to its revenue and controlling its costs.
Return on investment
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating return on assets (Operating ROA) | 21.27% | 19.62% | 19.87% | 19.75% | 20.33% | 21.92% | 22.66% | 21.54% | 20.61% | 19.36% | 17.71% | 16.01% | 11.97% | 12.60% | 13.03% | 12.34% | 12.01% | 11.43% | 10.78% | 12.03% |
| Return on assets (ROA) | 19.25% | 17.55% | 17.70% | 17.40% | 17.07% | 18.37% | 19.10% | 18.41% | 18.14% | 17.07% | 15.91% | 14.87% | 10.96% | 11.58% | 11.95% | 11.01% | 10.45% | 9.59% | 8.74% | 9.69% |
| Return on total capital | 54.13% | 46.38% | 49.95% | 52.82% | 60.26% | 69.21% | 81.54% | 86.59% | 72.13% | 73.49% | 82.26% | 35.57% | 20.84% | 22.13% | 22.47% | 20.86% | 20.73% | 18.72% | 17.85% | 19.07% |
| Return on equity (ROE) | 48.98% | 41.49% | 44.50% | 46.54% | 50.60% | 58.01% | 68.70% | 73.99% | 63.50% | 64.80% | 73.88% | 33.03% | 19.08% | 20.34% | 20.61% | 18.60% | 18.04% | 15.71% | 14.48% | 15.35% |
1. Operating Return on Assets (Operating ROA):
- Medpace Holdings Inc's Operating ROA has shown a positive trend over the quarters, increasing from 12.03% in March 2020 to 20.33% in December 2024.
- This indicates that the company has been efficiently generating operating income from its assets, with a significant improvement in performance over the years.
2. Return on Assets (ROA):
- The Return on Assets for Medpace Holdings Inc has also demonstrated a consistent upward trend, rising from 9.69% in March 2020 to 19.25% in December 2024.
- This signifies that the company has become more effective in generating profits relative to its total assets as time progressed.
3. Return on Total Capital:
- The Return on Total Capital has shown significant fluctuations over the quarters but generally exhibits an increasing trend, peaking at 86.59% in March 2023.
- Although there are fluctuations, the overall trend suggests that the company has been successful in utilizing its total capital effectively to generate returns.
4. Return on Equity (ROE):
- Medpace Holdings Inc's Return on Equity has shown a substantial improvement from 15.35% in March 2020 to 48.98% in December 2024.
- This indicates that the company has been rewarding its shareholders well in terms of generating profits from the equity invested.
In summary, the profitability ratios of Medpace Holdings Inc have generally improved over the years, reflecting the company's efficiency in utilizing its assets, generating returns from capital employed, and rewarding its shareholders. These positive trends suggest a healthy financial performance and effective management of resources.